🔥🐔 BizChicken 🐔🔥

Companies Similar to Virpax Pharmaceuticals, Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics, Inc. logo
Market Cap: Medium
Employees: Low

ARQ-151

Arcutis Biotherapeutics, Inc. is a biopharmaceutical company developing and commercializing treatments for dermatological diseases, including plaque psoriasis, atopic dermatitis, seborrheic dermatitis, scalp psoriasis, hand eczema, vitiligo, and alopecia areata.

Tags: alopecia areata, atopic dermatitis, biopharmaceutical, dermatological diseases, hand eczema, plaque psoriasis, scalp psoriasis, seborrheic dermatitis, vitiligo

Symbol: ARQT

Recent Price: $14.20

Industry: Biotechnology

CEO: Mr. Todd Franklin Watanabe M.A.

Sector: Healthcare

Employees: 296

Address: 3027 Townsgate Road, Westlake Village, CA 91361

Phone: 805 418 5006

Last updated: 2024-12-31

Evelo Biosciences, Inc.

Evelo Biosciences, Inc. logo
Market Cap: Lowest
Employees: Low

EDP1815

Evelo Biosciences, Inc. discovers and develops oral biologics for inflammatory diseases and cancer, with key products like EDP1815 in clinical trials.

Tags: biotechnology, cancer, clinical trials, inflammatory diseases, oral biologics

Symbol: EVLO

Recent Price: $0.00

Industry: Biotechnology

CEO: Mr. Craig R. Jalbert CIRA

Sector: Healthcare

Employees: 66

Address: 620 Memorial Drive, Cambridge, MA 02139

Phone: 617 577 0300

Last updated: 2024-12-31

Abivax SA American Depositary Shares

Abivax SA American Depositary Shares logo
Market Cap: Medium
Employees: Lowest

obefazimod

ABIVAX Société Anonyme is a clinical-stage biotechnology company developing therapeutics to modulate the immune response for chronic inflammatory diseases. Their lead drug candidate, obefazimod, is in Phase 3 clinical trials for ulcerative colitis.

Tags: biotechnology, chronic inflammatory diseases, clinical trials, immune response, ulcerative colitis

Symbol: ABVX

Recent Price: $7.05

Industry: Biotechnology

CEO: Mr. Marc M. P. de Garidel M.B.A.

Sector: Healthcare

Employees: 62

Address: 7-11 boulevard Haussmann, Paris, null 75009

Phone: 33 1 53 83 09 63

Leadership

  • Marc de Garidel, MBA, Chief Executive Officer
  • Didier Blondel, EVP, Chief Financial Officer & Board Secretary
  • Fabio Cataldi, MD, Chief Medical Officer
  • Ida Hatoum, Chief People Officer, Chief Compliance Officer
  • David Zhang, PhD, Chief Strategy Officer
  • Pierre Courteille, Pharmacist, MBA, Chief Business Officer
  • Didier Scherrer, PhD, Chief Scientific Officer
  • Jérôme Denis, PhD, EVP, Process Development & Manufacturing
  • Nadège Briancon-Eris, PhD, Senior Vice President, Global Head of Program Management
  • Sylvie Grégoire, PharmD, Chair of the Board
  • Corinna zur Bonsen-Thomas, Co-founder and CEO of RetInSight; Former General Counsel at Baxter/Baxalta International
  • Philippe Pouletty, MD, Founder of Abivax; Managing Partner of Truffle Capital
  • June Lee, MD FACCP, Venture Partner at 5AM Ventures
  • Kinam Hong, MD, MBA, CFA, Partner at the Crossover Fund Sofinnova
  • Troy Ignelzi, CFO of Rapport Therapeutics
  • Camilla Soenderby, Board Member of BB Biotech, F2G, and Affibody; Member of Novo Holdings Advisory Group; Industrial Advisor for EQT
  • Mary Mantock, Senior Vice President, Global Head of Regulatory Affairs
  • Hema Keshava, Senior Vice President, Finance
  • Cristina Damatarca, MD, PgD, Senior Vice President, Global Head of Drug Safety and Pharmacovigilance
  • Patrick Malloy, Senior Vice President, Investor Relations
  • Douglas Jacobstein, MD, Senior Vice President, Global Head of Clinical Development
  • Jennifer Fine, ScD, Senior Vice President, Global Head of HEOR and RWE
  • Kevin Shan, PhD, Vice President, Global Head of Biometrics
  • Chris Rabbat, PhD, Vice President, Global Head of Medical Affairs
  • Ana Sharma, MPH, Vice President, Global Head of Quality
  • Sophie LaCourrege, Vice President, HR Business Partner, Engagement and Culture

Last updated: 2024-12-31

Aquestive Therapeutics, Inc.

Aquestive Therapeutics, Inc. logo
Market Cap: Medium
Employees: Low

Sympazan, Suboxone, Zuplenz, Azstarys, Libervant, Exservan

Aquestive Therapeutics, Inc. is a pharmaceutical company committed to identifying, developing, and commercializing innovative products to address unmet medical needs, both in the U.S. and globally. It specializes in oral soluble film formulations for various treatments, including neurological conditions and opioid dependence.

Tags: ADHD, ALS, biotechnology, neurology, opioid dependence, oral soluble film, pharmaceutical

Symbol: AQST

Recent Price: $3.52

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Daniel Barber

Sector: Healthcare

Employees: 135

Address: 30 Technology Drive, Warren, NJ 07059

Phone: 908 941 1900

Last updated: 2024-12-31

Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc. logo
Market Cap: Lowest
Employees: Low

Acetadote, Caldolor, Kristalose, Omeclamox-Pak, Vaprisol, Vibativ, Redi Trex

Cumberland Pharmaceuticals Inc. focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology, offering various medications including injections and oral solutions.

Tags: gastroenterology, hospital care, oncology, pharmaceutical, prescription products, rheumatology

Symbol: CPIX

Recent Price: $2.42

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. A. J. Kazimi MBA

Sector: Healthcare

Employees: 91

Address: 2525 West End Avenue, Nashville, TN 37203

Phone: 615 255 0068

Last updated: 2024-12-31

Curis, Inc.

Curis, Inc. logo
Market Cap: Lowest
Employees: Lowest

Emavusertib

Curis, Inc. is a biotechnology company focused on discovering and developing drug candidates for treating human cancers, with a range of clinical stage and pipeline products targeting lymphomas, leukemia, and solid tumors.

Tags: biotechnology, cancer treatment, clinical trials, drug development, oncology

Symbol: CRIS

Recent Price: $3.14

Industry: Biotechnology

CEO: Mr. James E. Dentzer

Sector: Healthcare

Employees: 49

Address: Building C, Lexington, MA 02421

Phone: 617 503 6500

Leadership

  • Martyn D. Greenacre, Chair of the Board
  • John Hohneker, M.D., Director
  • Kenneth I. Kaitin, Ph.D., Director
  • Anne E. Borgman, M.D., Director
  • Marc Rubin, M.D., Director
  • James Dentzer, Chief Executive Officer and Director

Last updated: 2024-12-31

Ensysce Biosciences, Inc.

Ensysce Biosciences, Inc. logo
Market Cap: Lowest
Employees: Lowest

PF614, PF614-MPAR, PF329

Ensysce Biosciences, Inc. is a clinical-stage pharmaceutical company focused on developing prescription drugs for severe pain relief and opioid overdose protection using proprietary abuse-resistant technologies.

Tags: clinical trials, opioid, overdose protection, pain relief, pharmaceutical

Symbol: ENSC

Recent Price: $8.62

Industry: Biotechnology

CEO: Dr. D. Lynn Kirkpatrick Ph.D.

Sector: Healthcare

Employees: 7

Address: 7946 Ivanhoe Avenue, La Jolla, CA 92037

Phone: 858 263 4196

Last updated: 2024-12-31

Indaptus Therapeutics, Inc.

Indaptus Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

Decoy20

Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company focusing on the development of anti-cancer and anti-viral immunotherapy products, with its lead clinical candidate, Decoy20, targeting lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as viral infections.

Tags: Decoy20, anti-cancer, anti-viral, biotechnology, immunotherapy

Symbol: INDP

Recent Price: $0.87

Industry: Biotechnology

CEO: Mr. Jeffrey A. Meckler

Sector: Healthcare

Employees: 7

Address: 3 Columbus Circle, New York, NY 10019

Phone: 347 480 9760

Last updated: 2024-12-31

Innoviva, Inc.

Innoviva, Inc. logo
Market Cap: Medium
Employees: Low

RELVAR/BREO ELLIPTA, ANORO ELLIPTA, TRELEGY ELLIPTA

Innoviva, Inc. engages in the development and commercialization of pharmaceuticals, focusing on respiratory therapies with its product line including RELVAR/BREO ELLIPTA, ANORO ELLIPTA, and TRELEGY ELLIPTA. The company collaborates with Sarissa Capital Management and Glaxo Group Limited.

Tags: COPD, asthma, partnerships, pharmaceuticals, respiratory therapies

Symbol: INVA

Recent Price: $17.38

Industry: Biotechnology

CEO: Mr. Pavel Raifeld C.F.A.

Sector: Healthcare

Employees: 112

Address: 1350 Old Bayshore Highway, Burlingame, CA 94010

Phone: 650 238 9600

Last updated: 2024-12-31

Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated logo
Market Cap: High
Employees: Lowest

Kyprolis, Evomela, Veklury, Teriparatide, Vaxneuvance, Pneumosil, Rylaze, Nexterone, Zulresso, Noxafil-IV

Ligand Pharmaceuticals Incorporated is a biopharmaceutical company focused on developing or acquiring technologies to aid pharmaceutical companies in discovering and developing medicines. The company's commercial programs include treatments for multiple myeloma, COVID-19, osteoporosis, invasive diseases, childhood pneumonia, and acute lymphoblastic leukemia.

Tags: biopharmaceutical, commercial programs, disease treatment, medicine development, pharmaceutical technology

Symbol: LGND

Recent Price: $105.76

Industry: Biotechnology

CEO: Mr. Todd C. Davis Ph.D.

Sector: Healthcare

Employees: 58

Address: 5980 Horton Street, EmeryVille, CA 94608

Phone: 858 550 7500

Last updated: 2024-12-31

Pacira BioSciences, Inc.

Pacira BioSciences, Inc. logo
Market Cap: Medium
Employees: Medium

EXPAREL, ZILRETTA, iovera

Pacira Bio Sciences, Inc. offers non-opioid pain management and regenerative health solutions. Products include EXPAREL, ZILRETTA, and the iovera system. The company focuses on drug delivery technology with a proprietary multivesicular liposome system.

Tags: drug delivery, healthcare, non-opioid, pain management, regenerative health

Symbol: PCRX

Recent Price: $18.94

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Frank D. Lee

Sector: Healthcare

Employees: 711

Address: 5401 West Kennedy Boulevard, Tampa, FL 33609

Phone: 813 553 6680

Leadership

  • Frank D. Lee, Chief Executive Officer and member of the Board of Directors
  • Paul J Hastings, Chair of the Board of Directors
  • Marcelo Bigal, MD, PhD, President and Chief Executive Officer of Ventus Therapeutics
  • Laura Brege, Former CEO of Nodality, Inc.
  • Abraham Ceesay, Chief Executive Officer of Rapport Therapeutics
  • Chris Christie, Director
  • Mark I. Froimson, MD, Principal at Riverside Health Advisors
  • Mark Kronenfeld, MD, Chairman of Anesthesiology at Maimonides Medical Center
  • Andreas Wicki, PhD, Chief Executive Officer of HBM Healthcare Investments AG
  • Michael Yang, Former Chief Executive Officer of ViaCyte
  • Alethia Young, Chief Financial Officer of Bicycle Therapeutics

Last updated: 2024-12-31

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc. logo
Market Cap: High
Employees: Medium

Crysvita, Mepsevii, Dojolvi, Evkeeza, DTX401, DTX301

Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company focused on the development and commercialization of products for rare and ultra-rare genetic diseases worldwide.

Tags: Crysvita, Dojolvi, Evkeeza, Mepsevii, biopharmaceutical, gene therapy, genetic diseases, rare diseases

Symbol: RARE

Recent Price: $42.27

Industry: Biotechnology

CEO: Dr. Emil D. Kakkis M.D., Ph.D.

Sector: Healthcare

Employees: 1276

Address: 60 Leveroni Court, Novato, CA 94949

Phone: 415 483 8800

Last updated: 2024-12-31

Vincerx Pharma, Inc.

Vincerx Pharma, Inc. logo
Market Cap: Lowest
Employees: Lowest

VIP152

Vincerx Pharma, Inc. is a clinical-stage biopharmaceutical company focused on researching and developing therapies to address unmet medical needs for cancer treatment in the United States. Their lead product candidate, VIP152, is a cyclin-dependent kinase-9 inhibitor for advanced cancer.

Tags: biopharmaceutical, cancer treatment, clinical-stage, oncology, therapy development

Symbol: VINC

Recent Price: $0.33

Industry: Biotechnology

CEO: Dr. Ahmed M. Hamdy M.D.

Sector: Healthcare

Employees: 42

Address: 260 Sheridan Avenue, Palo Alto, CA 94306

Phone: 650 800 6676

Last updated: 2024-12-31

Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc. logo
Market Cap: Lowest
Employees: Low

VP-102, VP-103

Verrica Pharmaceuticals Inc. develops and commercializes treatments for skin diseases in the United States, including products for molluscum contagiosum and warts. The company collaborates with Torii Pharmaceutical Co., Ltd., and Lytix Biopharma AS for further development and commercialization efforts.

Tags: dermatology, molluscum contagiosum, oncology, pharmaceuticals, skin diseases, warts

Symbol: VRCA

Recent Price: $0.70

Industry: Biotechnology

CEO: Mr. Ted White

Sector: Healthcare

Employees: 100

Address: 44 West Gay Street, West Chester, PA 19380

Phone: 484 453 3300

Last updated: 2024-12-31

Virpax Pharmaceuticals, Inc.

Virpax Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

Epoladerm, Probudur, Envelta, PES200, An Qlar, VRP324

Virpax Pharmaceuticals, Inc. is a preclinical-stage pharmaceutical company dedicated to developing drug-delivery systems and technologies for non-opioid, non-addictive pain management and treatments for central nervous system disorders.

Tags: Envelta, Epoladerm, Probudur, central nervous system, drug-delivery, non-opioid, pain management, pharmaceutical, preclinical

Symbol: VRPX

Recent Price: $0.45

Industry: Biotechnology

CEO: Mr. Jatinder Dhaliwal

Sector: Healthcare

Employees: 7

Address: 1055 Westlakes Drive, Berwyn, PA 19312

Phone: 610 727 4597

Last updated: 2024-12-31

AbbVie Inc.

AbbVie Inc. logo
Market Cap: Highest
Employees: Highest

HUMIRA, SKYRIZI, RINVOQ, IMBRUVICA, VENCLEXTA, MAVYRET, CREON, Synthroid, Linzess/Constella, Lupron

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide, offering a range of therapies including HUMIRA for autoimmune diseases and MAVYRET for HCV infection.

Tags: autoimmune diseases, biotechnology, gastroenterology, healthcare, oncology, pharmaceuticals

Symbol: ABBV

Recent Price: $176.20

Industry: Drug Manufacturers - General

CEO: Mr. Robert A. Michael

Sector: Healthcare

Employees: 50000

Address: 1 North Waukegan Road, North Chicago, IL 60064-6400

Phone: 847 932 7900

Last updated: 2024-12-31

Eagle Pharmaceuticals, Inc.

Eagle Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Low

Ryanodex, Belrapzo, Bendeka, EP-4104, PEMFEXY, EA-114, Vasopressin

Eagle Pharmaceuticals, Inc. specializes in the development and commercialization of pharmaceutical products targeting diseases of the central nervous system, metabolic critical care, and oncology in the U.S. Notable products include Ryanodex for malignant hyperthermia, and oncology treatments Belrapzo and Bendeka.

Tags: antitoxin, central nervous system, collaboration agreements, critical care, disease treatment, oncology, pharmaceutical

Symbol: EGRX

Recent Price: $0.50

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Michael Graves

Sector: Healthcare

Employees: 134

Address: 50 Tice Boulevard, Woodcliff Lake, NJ 07677

Phone: 201 326 5300

Last updated: 2024-12-31

Indivior PLC

Indivior PLC logo
Market Cap: High
Employees: Medium

SUBLOCADE, SUBUTEX PRO, SUBOXONE, SUBUTEX, OPVEE, PERSERIS

Indivior PLC is focused on the development, manufacture, and sale of buprenorphine-based prescription drugs for opioid dependence and co-occurring disorders. The company's products treat substance use disorders, serious mental illnesses, and opioid overdose prevention, and they include SUBLOCADE, SUBUTEX PRO, SUBOXONE, SUBUTEX, OPVEE, and PERSERIS. Indivior is also advancing INDV-2000, a new treatment in the clinical trial phase.

Tags: Addiction Medicine, Clinical Trials, Mental Health, Opioid Treatment, Pharmaceuticals, Substance Use Disorders

Symbol: INDV

Recent Price: $12.18

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Mark Crossley

Sector: Healthcare

Employees: 1000

Address: 10710 Midlothian Turnpike, North Chesterfield, VA 23235

Phone: 804 379 1090

Last updated: 2024-12-31

Nuvectis Pharma, Inc.

Nuvectis Pharma, Inc. logo
Market Cap: Low
Employees: Lowest

NXP800, NXP900

Nuvectis Pharma, Inc., is a biopharmaceutical company that focuses on developing precision medicines for treating serious unmet medical needs in oncology. It is working on products like NXP800, a heat shock factor 1 pathway inhibitor, and NXP900, a drug candidate targeting Proto-oncogene c-Src and YES1 kinases.

Tags: NXP800, NXP900, biopharmaceutical, oncology, precision medicine

Symbol: NVCT

Recent Price: $5.14

Industry: Biotechnology

CEO: Mr. Ron Bentsur M.B.A.

Sector: Healthcare

Employees: 13

Address: 1 Bridge Plaza, Fort Lee, NJ 07024

Phone: 201 614 3150

Last updated: 2024-12-31

Ventyx Biosciences, Inc.

Ventyx Biosciences, Inc. logo
Market Cap: Low
Employees: Low

VTX958

Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecule product candidates for the treatment of inflammatory diseases and autoimmune disorders. Key products include VTX958 for immune-mediated diseases, VTX002 for ulcerative colitis, and VTX2735 for systemic inflammatory diseases.

Tags: VTX002, VTX2735, VTX958, autoimmune disorders, biopharmaceutical, clinical trials, inflammatory diseases, small molecule

Symbol: VTYX

Recent Price: $2.23

Industry: Biotechnology

CEO: Dr. Raju S. Mohan Ph.D.

Sector: Healthcare

Employees: 73

Address: 662 Encinitas Boulevard, Encinitas, CA 92024

Phone: 760 593 4832

Last updated: 2024-12-31